先前未经治疗的,局部先进的,不可经过的或转移性三重阴性乳腺癌的参与者中,对Izalontamab Brengitecan与化学疗法的研究研究了抗PD(L)1药物(Izabright-Breast-Breast-Breast-Breast-Breast-Breast01)
Izalontamab Brengitecan(BMS-986507)的一项随机,开放标签,推断,无缝的2/3期研究,与先前未经治疗,局部先进,经常性不合适的或转移性三重乳腺癌(TNBC)或磨损的患者对医师的选择相对于医师选择的治疗抗PD1/PD-L1处理
The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physician's choice (TPC) (paclitaxel, nab-paclitaxel, carboplatin plus gemcitabine, and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen receptor (ER)-low, human epidermal growth factor receptor 2 (HER2)-negative BC patients who are not candidates for anti-PD(L)1 therapy and endocrine therapies.
研究概览
地位
地位
干预/治疗
干预/治疗
研究类型
研究类型
注册 (估计的)
注册
阶段
阶段
- 阶段2
- 第三阶段
联系人和位置
学习联系方式
学习联系方式
- 姓名:First line of the email MUST contain NCT # and Site #.
研究联系人备份
- 姓名:BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
- 电话号码:855-907-3286
- 邮箱:Clinical.Trials@bms.com
学习地点
-
-
-
Guangzhou、中国、510060
- 招聘中
- Sun Yat-sen University Cancer Center
-
接触:
- Shusen Wang, Site 1025
- 电话号码:8613926168469
-
-
Anhui
-
Hefei、Anhui、中国、230001
- 招聘中
- Anhui Provincial Hospital
-
接触:
- Nannan Lu, Site 1002
- 电话号码:8618130056850
-
Hefei、Anhui、中国、230601
- 招聘中
- The Second Hospital of Anhui Medical University
-
接触:
- Fanfan Li, Site 1003
- 电话号码:+8613855137365
-
-
BEI
-
Beijing、BEI、中国、100021
- 招聘中
- Cancer Hospital Chinese Academy of Medical Sciences
-
接触:
- Binghe Xu, Site 1001
- 电话号码:+86 13501028690
-
-
Beijing Municipality
-
Beijing、Beijing Municipality、中国、100142
- 招聘中
- Beijing Cancer Hospital
-
接触:
- Huiping Li, Site 1005
- 电话号码:8613811012595
-
Beijing、Beijing Municipality、中国、100142
- 招聘中
- China-Japan Friendship Hospital
-
接触:
- Donggui Wan, Site 1024
- 电话号码:8619854715414
-
-
Fujian
-
Fuzhou、Fujian、中国、350000
- 招聘中
- Fujian Cancer Hospital
-
接触:
- Fan Wu, Site 1006
- 电话号码:8613859082118
-
Fyzhou、Fujian、中国、350001
- 招聘中
- Fujian Medical University Union Hospital
-
接触:
- Fangmeng Fu, Site 1007
- 电话号码:8613365917923
-
Xiamen、Fujian、中国、361003
- 撤销
- Local Institution - 1016
-
-
Gansu
-
Lanzhou、Gansu、中国、730000
- 招聘中
- The First Hospital of Lanzhou University
-
接触:
- Xiaoling Ling, Site 1031
- 电话号码:8618693165668
-
-
Guangxi
-
Nanning、Guangxi、中国、530021
- 招聘中
- Guangxi Medical University Affiliated Cancer Hospital
-
接触:
- Wei Wei, Site 1008
- 电话号码:8618577071966
-
-
HUN
-
Changsha、HUN、中国、410013
- 尚未招聘
- Local Institution - 1011
-
接触:
- Site 1011
-
-
Harbin
-
Harbin、Harbin、中国、150001
- 招聘中
- The First Hospital of harbin University
-
接触:
- Li Cai, Site 1028
- 电话号码:8613313602929
-
-
Henan
-
Anyang、Henan、中国、455110
- 招聘中
- Anyang Cancer Hospital
-
接触:
- Junlan Guo, Site 1004
- 电话号码:8615037272967
-
Zhengzhou、Henan、中国、450008
- 招聘中
- Henan Cancer Hospital
-
接触:
- Min Yan, Site 1009
- 电话号码:8615713857388
-
Zhengzhou、Henan、中国、450052
- 招聘中
- The First Affiliated Hospital of Zhengzhou University
-
接触:
- Wei He, Site 1032
- 电话号码:+8618638553286
-
-
Hubei
-
Wuhan、Hubei、中国、430070
- 招聘中
- Hubei Cancer Hospital
-
接触:
- Xinhong Wu, Site 1010
- 电话号码:8618602726300
-
Wuhan、Hubei、中国、430061
- 招聘中
- Zhongnan Hospital of Wuhan University
-
接触:
- Haijun Yu, Site 1021
- 电话号码:8613971665181
-
Xiangyang、Hubei、中国、441000
- 招聘中
- Xiangyang Central Hospital
-
接触:
- Yuehua Wang, Site 1022
- 电话号码:8613995777482
-
-
Jiangxi
-
Nanchang、Jiangxi、中国、330029
- 招聘中
- Jiangxi Cancer Hospital
-
接触:
- Zhengkui Sun, Site 1013
- 电话号码:8613907000210
-
-
Liaoning
-
Changchun、Liaoning、中国、130021
- 尚未招聘
- Local Institution - 1012
-
接触:
- Site 1012
-
Shenyang、Liaoning、中国、140001
- 招聘中
- Liaoning Cancer Hospital
-
接触:
- Tao Sun, Site 1014
- 电话号码:8613940404526
-
-
Shandong
-
Jinan、Shandong、中国、250117
- 招聘中
- Cancer Hospital of Shandong First Medical University
-
接触:
- Huihui Li, Site 1017
- 电话号码:8615553103209
-
Qingdao、Shandong、中国、266071
- 招聘中
- The Affiliated Hospital Of Qingdao University
-
接触:
- Haibo Wang, Site 1015
- 电话号码:8618661805787
-
-
Shanxi
-
Taiyuan、Shanxi、中国、650118
- 招聘中
- Shanxi Cancer Hospital
-
接触:
- Guohui Han, Site 1018
- 电话号码:8613454858188
-
-
Sichuan
-
Chengdu、Sichuan、中国、610072
- 招聘中
- Sichuan Provincial People'S Hospital
-
接触:
- Jing Luo, Site 1019
- 电话号码:8618981838521
-
-
Tianjin Municipality
-
Tianjin、Tianjin Municipality、中国、300060
- 招聘中
- Tianjin Cancer Hospital Airport Hospital
-
接触:
- Chunfang Hao, Site 1027
- 电话号码:8613602031629
-
Tianjin、Tianjin Municipality、中国、301000
- 招聘中
- Tianjin Medical University Cancer Institute & Hospital
-
接触:
- Yehui Shi, Site 1020
- 电话号码:8618622221183
-
-
Yunnan
-
Kunming、Yunnan、中国、650118
- 招聘中
- Yunnan Cancer Hospital
-
接触:
- Guojun Zhang, Site 1029
- 电话号码:8618850064298
-
-
Zhejiang
-
Hangzhou、Zhejiang、中国、310024
- 招聘中
- The First Affiliated Hospital, Zhejiang University School of Medicine
-
接触:
- Peifen Fu, Site 1023
- 电话号码:8613958161556
-
Hangzhou、Zhejiang、中国、310022
- 尚未招聘
- Local Institution - 1040
-
接触:
- Site 1040
-
-
-
-
Central District
-
Petah Tikva、Central District、以色列、4941492
- 尚未招聘
- Local Institution - 0186
-
接触:
- Site 0186
-
Ramat Gan、Central District、以色列、5265601
- 主动,不招人
- Local Institution - 0044
-
-
Jerusalem
-
Jerusalem、Jerusalem、以色列、9112001
- 完全的
- Local Institution - 0047
-
-
Northern District
-
Hadera、Northern District、以色列、38100
- 主动,不招人
- Local Institution - 0048
-
Haifa、Northern District、以色列、3109601
- 主动,不招人
- Local Institution - 0123
-
-
-
-
British Columbia
-
Kelowna、British Columbia、加拿大、V1Y 5L3
- 招聘中
- BC Cancer Kelowna
-
接触:
- Susan Ellard, Site 0218
- 电话号码:+1250-712-3996
-
Victoria、British Columbia、加拿大、V8R 6V5
- 撤销
- Local Institution - 0217
-
-
Ontario
-
Ottawa、Ontario、加拿大、K1H 8L6
- 招聘中
- The Ottawa Hospital - General Campus
-
接触:
- Xinni Song, Site 0265
- 电话号码:6137377700ext70208
-
-
Quebec
-
Montreal、Quebec、加拿大、H4A 3J1
- 招聘中
- McGill University Health Centre
-
接触:
- Jamil Asselah, Site 0219
- 电话号码:514934193435721
-
Montreal、Quebec、加拿大、H2X 3E4
- 招聘中
- Centre Hospitalier de l'Université de Montréal
-
接触:
- Danielle Charpentier, Site 0215
- 电话号码:5148908000
-
Saint-Charles-Borromée、Quebec、加拿大、J6E 6J2
- 招聘中
- Centre Intégré de Santé et de Services Sociaux de Lanaudière
-
接触:
- Angélique Brunot, Site 0350
- 电话号码:579-593-1172
-
Sherbrooke、Quebec、加拿大、J1H 5N4
- 招聘中
- Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CIUS
-
接触:
- Michel Pavic, Site 0216
- 电话号码:819-346-1110x74816
-
-
-
-
-
Johannesburg、南非、2193
- 撤销
- Local Institution - 0342
-
Pretoria、南非、0001
- 撤销
- Local Institution - 0336
-
Pretoria、南非、0084
- 撤销
- Local Institution - 0341
-
Soweto、南非、2013
- 撤销
- Local Institution - 0340
-
-
Eastern Cape
-
East London、Eastern Cape、南非、5241
- 尚未招聘
- Local Institution - 0351
-
接触:
- Site 0351
-
-
Western Cape
-
Cape Town、Western Cape、南非、7570
- 撤销
- Local Institution - 1034
-
-
-
-
Maharashtra
-
Mumbai、Maharashtra、印度、400 057
- 撤销
- Local Institution - 0337
-
Mumbai、Maharashtra、印度、400012
- 撤销
- Local Institution - 0131
-
Nagpur、Maharashtra、印度、440001
- 撤销
- Local Institution - 0134
-
-
National Capital Territory of Delhi
-
New Delhi、National Capital Territory of Delhi、印度、110017
- 撤销
- Local Institution - 0352
-
New Delhi、National Capital Territory of Delhi、印度、110029
- 撤销
- Local Institution - 0266
-
New Delhi、National Capital Territory of Delhi、印度、110085
- 撤销
- Local Institution - 0206
-
-
Tamil Nadu
-
Chennai、Tamil Nadu、印度、600035
- 撤销
- Local Institution - 0125
-
-
Telangana
-
Hyderabad、Telangana、印度、500082
- 撤销
- Local Institution - 0130
-
-
Uttar Pradesh
-
Varanasi、Uttar Pradesh、印度、221005
- 撤销
- Local Institution - 0133
-
-
-
-
-
Medellín、哥伦比亚、050030
- 尚未招聘
- Local Institution - 0349
-
接触:
- Site 0349
-
-
Antioquia
-
Medellín、Antioquia、哥伦比亚、50021
- 撤销
- Local Institution - 0195
-
Rionegro、Antioquia、哥伦比亚、054047
- 尚未招聘
- Local Institution - 0201
-
接触:
- Site 0201
-
-
Atlántico
-
Barranquilla、Atlántico、哥伦比亚、080020
- 尚未招聘
- Local Institution - 0194
-
接触:
- Site 0194
-
Puerto Colombia、Atlántico、哥伦比亚、81001
- 撤销
- Local Institution - 0182
-
-
COR
-
Montería、COR、哥伦比亚、230002
- 尚未招聘
- Local Institution - 0181
-
接触:
- Site 0181
-
-
Cundinamarca
-
Bogota、Cundinamarca、哥伦比亚、111151
- 尚未招聘
- Local Institution - 0327
-
接触:
- Site 0327
-
-
Valle del Cauca Department
-
Cali、Valle del Cauca Department、哥伦比亚、760032
- 尚未招聘
- Local Institution - 0183
-
接触:
- Site 0183
-
-
-
-
-
Adana、土耳其(türkiye)、01123
- 尚未招聘
- Local Institution - 0361
-
接触:
- Site 0361
-
Ankara、土耳其(türkiye)、06800
- 尚未招聘
- Local Institution - 0362
-
接触:
- Site 0362
-
Istanbul、土耳其(türkiye)、34722
- 尚未招聘
- Local Institution - 0363
-
接触:
- Site 0363
-
Istanbul、土耳其(türkiye)、34010
- 尚未招聘
- Local Institution - 0364
-
接触:
- Site 0364
-
-
-
-
-
Chihuahua City、墨西哥、31207
- 招聘中
- Scientia Investigacion Clinica S.C.
-
接触:
- Enrique Zamudio Lozoya, Site 0174
- 电话号码:6146883416
-
-
DIF
-
Mexico City、DIF、墨西哥、03100
- 招聘中
- CENEIT Oncologicos
-
接触:
- Alberto Suarez Zaizar, Site 0177
- 电话号码:525555342400
-
-
Estado de Baja California
-
Tijuana、Estado de Baja California、墨西哥、22010
- 尚未招聘
- Local Institution - 0264
-
接触:
- Site 0264
-
-
Jalisco
-
Guadalajara、Jalisco、墨西哥、44680
- 尚未招聘
- Local Institution - 0178
-
接触:
- Site 0178
-
-
Mexico City
-
Mexico City、Mexico City、墨西哥、14070
- 尚未招聘
- Local Institution - 0329
-
接触:
- Site 0329
-
-
Nuevo León
-
Monterrey、Nuevo León、墨西哥、64320
- 尚未招聘
- Local Institution - 0175
-
接触:
- Site 0175
-
Monterrey、Nuevo León、墨西哥、64460
- 尚未招聘
- Local Institution - 0176
-
接触:
- Site 0176
-
Monterrey、Nuevo León、墨西哥、64460
- 撤销
- Local Institution - 0355
-
-
Oaxaca
-
Oaxaca City、Oaxaca、墨西哥、68020
- 尚未招聘
- Local Institution - 0173
-
接触:
- Site 0173
-
-
Yucatán
-
Mérida、Yucatán、墨西哥、97000
- 尚未招聘
- Local Institution - 0179
-
接触:
- Site 0179
-
-
-
-
-
Salzburg、奥地利、5020
- 主动,不招人
- Local Institution - 0267
-
Sankt Pölten、奥地利、3100
- 主动,不招人
- Local Institution - 0270
-
Vienna、奥地利、1090
- 主动,不招人
- Local Institution - 0269
-
-
Styria
-
Graz、Styria、奥地利、8036
- 主动,不招人
- Local Institution - 0292
-
-
Tyrol
-
Innsbruck、Tyrol、奥地利、6020
- 主动,不招人
- Local Institution - 0268
-
-
-
-
-
Rio de Janeiro、巴西、20230-130
- 主动,不招人
- Local Institution - 0153
-
São Paulo、巴西、01317-000
- 主动,不招人
- Local Institution - 0144
-
São Paulo、巴西、01401-002
- 主动,不招人
- Local Institution - 0149
-
-
Amazonas
-
Manaus、Amazonas、巴西、69020-030
- 撤销
- Local Institution - 0187
-
-
Ceará
-
Fortaleza、Ceará、巴西、60135-237
- 主动,不招人
- Local Institution - 0147
-
-
Espírito Santo
-
Vitória、Espírito Santo、巴西、29055450
- 完全的
- Local Institution - 0157
-
-
Federal District
-
Lago Sul、Federal District、巴西、71681-603
- 撤销
- Local Institution - 1038
-
-
Paraná
-
Curitiba、Paraná、巴西、81480-580
- 完全的
- Local Institution - 0159
-
-
Rio Grande do Sul
-
Porto Alegre、Rio Grande do Sul、巴西、90470-340
- 完全的
- Local Institution - 0199
-
-
São Paulo
-
Barretos、São Paulo、巴西、14784400
- 主动,不招人
- Local Institution - 0148
-
São José do Rio Preto、São Paulo、巴西、15090000
- 主动,不招人
- Local Institution - 0164
-
-
-
-
Attica
-
Athens、Attica、希腊、11528
- 撤销
- Local Institution - 0043
-
-
Attikí
-
Athens、Attikí、希腊、115 22
- 主动,不招人
- Local Institution - 0042
-
Athens、Attikí、希腊、185 47
- 完全的
- Local Institution - 0038
-
-
Irakleío
-
Heraklion、Irakleío、希腊、715 00
- 完全的
- Local Institution - 0086
-
-
-
-
-
Berlin、德国、10117
- 主动,不招人
- Local Institution - 0261
-
Berlin、德国、10967
- 主动,不招人
- Local Institution - 0260
-
Bonn、德国、53111
- 主动,不招人
- Local Institution - 0259
-
Dresden、德国、01307
- 主动,不招人
- Local Institution - 0258
-
Heidelberg、德国、D-69120
- 主动,不招人
- Local Institution - 0262
-
Ulm、德国、89081
- 主动,不招人
- Local Institution - 0291
-
-
Baden-Wurttemberg
-
Esslingen am Neckar、Baden-Wurttemberg、德国、73730
- 主动,不招人
- Local Institution - 0320
-
-
Bavaria
-
Augsburg、Bavaria、德国、86156
- 主动,不招人
- Local Institution - 0256
-
München、Bavaria、德国、80637
- 主动,不招人
- Local Institution - 0271
-
-
Hesse
-
Frankfurt am Main、Hesse、德国、60590
- 主动,不招人
- Local Institution - 0306
-
Langen、Hesse、德国、63225
- 主动,不招人
- Local Institution - 0333
-
-
Lower Saxony
-
Hanover、Lower Saxony、德国、30625
- 主动,不招人
- Local Institution - 0257
-
-
North Rhine-Westphalia
-
Düsseldorf、North Rhine-Westphalia、德国、40235
- 完全的
- Local Institution - 0293
-
Essen、North Rhine-Westphalia、德国、45136
- 主动,不招人
- Local Institution - 0263
-
-
Saxony
-
Leipzig、Saxony、德国、04103
- 尚未招聘
- Local Institution - 0254
-
接触:
- Site 0254
-
-
Schleswig-Holstein
-
Lübeck、Schleswig-Holstein、德国、23538
- 完全的
- Local Institution - 0255
-
-
-
-
-
Milan、意大利、20141
- 主动,不招人
- Local Institution - 0052
-
Naples、意大利、80131
- 完全的
- Local Institution - 0058
-
Novara、意大利、28100
- 完全的
- Local Institution - 0061
-
Padova、意大利、35128
- 完全的
- Local Institution - 0056
-
Roma、意大利、00168
- 主动,不招人
- Local Institution - 0062
-
-
Campania
-
Naples、Campania、意大利、80131
- 主动,不招人
- Local Institution - 0051
-
-
Emilia-Romagna
-
Bologna、Emilia-Romagna、意大利、40138
- 完全的
- Local Institution - 0049
-
-
Friuli Venezia Giulia
-
Aviano、Friuli Venezia Giulia、意大利、33081
- 主动,不招人
- Local Institution - 0057
-
-
Liguria
-
Genoa、Liguria、意大利、16132
- 完全的
- Local Institution - 0054
-
-
Pisa
-
Pontedera、Pisa、意大利、56025
- 主动,不招人
- Local Institution - 0053
-
-
Tuscany
-
Prato、Tuscany、意大利、59100
- 完全的
- Local Institution - 0055
-
-
-
-
-
Fukuoka、日本、811-1395
- 撤销
- Local Institution - 0242
-
Fukushima、日本、960-1295
- 撤销
- Local Institution - 0225
-
Hiroshima、日本、7308518
- 撤销
- Local Institution - 0243
-
Kyoto、日本、606-8507
- 撤销
- Local Institution - 0235
-
Okayama、日本、700-8558
- 撤销
- Local Institution - 0241
-
Osaka、日本、541-8567
- 撤销
- Local Institution - 0239
-
-
Aichi-ken
-
Nagoya、Aichi-ken、日本、464-8681
- 撤销
- Local Institution - 0236
-
-
Chiba
-
Chiba、Chiba、日本、260-8717
- 撤销
- Local Institution - 0230
-
-
Ehime
-
Matsuyama、Ehime、日本、791-0280
- 撤销
- Local Institution - 0240
-
-
Gunma
-
Otashi、Gunma、日本、373-8550
- 撤销
- Local Institution - 0226
-
-
Hokkaido
-
Sapporo、Hokkaido、日本、003-0804
- 撤销
- Local Institution - 0222
-
-
Ishikawa-ken
-
Kanazawa、Ishikawa-ken、日本、920-8530
- 撤销
- Local Institution - 0232
-
-
Kagoshima-ken
-
Kagoshima、Kagoshima-ken、日本、892-0833
- 撤销
- Local Institution - 0244
-
-
Kanagawa
-
Isehara、Kanagawa、日本、259-1193
- 撤销
- Local Institution - 0234
-
Yokohama、Kanagawa、日本、2418515
- 撤销
- Local Institution - 0237
-
-
Mie-ken
-
Tsu、Mie-ken、日本、514-8507
- 撤销
- Local Institution - 0246
-
-
Miyagi
-
Sendai、Miyagi、日本、980-8574
- 撤销
- Local Institution - 0223
-
-
Osaka
-
Suita、Osaka、日本、565-0871
- 撤销
- Local Institution - 0238
-
-
Saitama
-
Hidaka、Saitama、日本、350-1298
- 撤销
- Local Institution - 0227
-
Ina-machi、Saitama、日本、362-0806
- 撤销
- Local Institution - 0224
-
-
Tokyo
-
Bunkyo-ku、Tokyo、日本、113-8431
- 撤销
- Local Institution - 0231
-
Chuo-ku、Tokyo、日本、104-0045
- 撤销
- Local Institution - 0229
-
Koto、Tokyo、日本、135-8550
- 撤销
- Local Institution - 0228
-
Shinagawa-ku、Tokyo、日本、142-8666
- 撤销
- Local Institution - 0245
-
Shinjuku-ku、Tokyo、日本、160-0023
- 撤销
- Local Institution - 0233
-
-
-
-
Santiago Metropolitan
-
Santiago、Santiago Metropolitan、智利、7500921
- 完全的
- Local Institution - 0138
-
Santiago、Santiago Metropolitan、智利、7650568
- 主动,不招人
- Local Institution - 0021
-
Santiago、Santiago Metropolitan、智利、8330032
- 主动,不招人
- Local Institution - 0017
-
Santiago、Santiago Metropolitan、智利、8420383
- 主动,不招人
- Local Institution - 0018
-
-
Valparaiso
-
Viña del Mar、Valparaiso、智利、2520598
- 完全的
- Local Institution - 0016
-
-
-
-
-
Lille、法国、59000
- 完全的
- Local Institution - 0094
-
Paris、法国、75248
- 撤销
- Local Institution - 0088
-
-
Aquitaine
-
Bordeaux、Aquitaine、法国、33076
- 主动,不招人
- Local Institution - 0089
-
-
Auvergne-Rhône-Alpes
-
Lyon、Auvergne-Rhône-Alpes、法国、69008
- 撤销
- Local Institution - 0090
-
-
Côte-d'Or
-
Dijon、Côte-d'Or、法国、21079
- 完全的
- Local Institution - 0272
-
-
Haute-Garonne
-
Toulouse、Haute-Garonne、法国、31059
- 撤销
- Local Institution - 0098
-
-
Hérault
-
Montpellier、Hérault、法国、34298
- 招聘中
- Institut Régional du Cancer Montpellier
-
接触:
- Marie Alexandre, Site 0095
- 电话号码:33467612393
-
-
Ille-et-Vilaine
-
Rennes、Ille-et-Vilaine、法国、35042
- 完全的
- Local Institution - 0099
-
-
Loire-Atlantique
-
Saint-Herblain、Loire-Atlantique、法国、44805
- 完全的
- Local Institution - 0092
-
-
Marne
-
Reims、Marne、法国、51726
- 撤销
- Local Institution - 0091
-
-
Paris
-
Villejuif、Paris、法国、94800
- 主动,不招人
- Local Institution - 0097
-
-
Provence-Alpes-Côte d'Azur Region
-
Marseille、Provence-Alpes-Côte d'Azur Region、法国、13273
- 招聘中
- Institut Paoli-Calmettes
-
接触:
- Alexandre Tassin de Nonneville, Site 0093
- 电话号码:0033621713044
-
-
Puy-de-Dôme
-
Clermont-Ferrand、Puy-de-Dôme、法国、63011
- 招聘中
- Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne
-
接触:
- Olivier Collard, Site 0096
- 电话号码:33473278005
-
-
Vienne
-
Poitiers、Vienne、法国、86021
- 撤销
- Local Institution - 1033
-
-
-
-
Greater Poland Voivodeship
-
Skórzewo、Greater Poland Voivodeship、波兰、60-185
- 主动,不招人
- Local Institution - 0189
-
-
Lublin Voivodeship
-
Biała Podlaska、Lublin Voivodeship、波兰、21-500
- 撤销
- Local Institution - 0074
-
-
Masovian Voivodeship
-
Warsaw、Masovian Voivodeship、波兰、02-781
- 尚未招聘
- Local Institution - 0072
-
接触:
- Site 0072
-
Warsaw、Masovian Voivodeship、波兰、03-411
- 主动,不招人
- Local Institution - 0220
-
-
Opole Voivodeship
-
Opole、Opole Voivodeship、波兰、45-061
- 尚未招聘
- Local Institution - 0076
-
接触:
- Site 0076
-
-
Łódź Voivodeship
-
Lodz、Łódź Voivodeship、波兰、93-338
- 主动,不招人
- Local Institution - 0221
-
-
-
-
New South Wales
-
Macquarie University、New South Wales、澳大利亚、2109
- 主动,不招人
- Local Institution - 0170
-
-
Queensland
-
Brisbane、Queensland、澳大利亚、4029
- 主动,不招人
- Local Institution - 0035
-
-
Victoria
-
Ballarat Central、Victoria、澳大利亚、3350
- 主动,不招人
- Local Institution - 0197
-
Heidelberg、Victoria、澳大利亚、3084
- 主动,不招人
- Local Institution - 0031
-
Melbourne、Victoria、澳大利亚、3000
- 主动,不招人
- Local Institution - 0274
-
-
Western Australia
-
Subiaco、Western Australia、澳大利亚、6008
- 完全的
- Local Institution - 0028
-
-
-
-
Skåne Län [se-12]
-
Malmö、Skåne Län [se-12]、瑞典、205 02
- 主动,不招人
- Local Institution - 0252
-
-
Stockholms Län [se-01]
-
Stockholm、Stockholms Län [se-01]、瑞典、112 19
- 主动,不招人
- Local Institution - 0026
-
-
Uppsala Län [se-03]
-
Uppsala、Uppsala Län [se-03]、瑞典、751 85
- 主动,不招人
- Local Institution - 0025
-
-
Örebro Län [se-18]
-
Örebro、Örebro Län [se-18]、瑞典、701 85
- 主动,不招人
- Local Institution - 0024
-
-
Östergötlands Län [se-05]
-
Linköping、Östergötlands Län [se-05]、瑞典、581 85
- 主动,不招人
- Local Institution - 0247
-
-
-
-
-
Zurich、瑞士、8008
- 主动,不招人
- Local Institution - 0251
-
-
Canton of St. Gallen
-
Sankt Gallen、Canton of St. Gallen、瑞士、9007
- 主动,不招人
- Local Institution - 0250
-
-
Canton of Vaud
-
Lausanne、Canton of Vaud、瑞士、1011
- 主动,不招人
- Local Institution - 0249
-
-
-
-
-
Bucharest、罗马尼亚、011171
- 主动,不招人
- Local Institution - 0083
-
Cluj-Napoca、罗马尼亚、400015
- 主动,不招人
- Local Institution - 0077
-
Dumbrăviţa、罗马尼亚、307160
- 完全的
- Local Institution - 0211
-
Iași、罗马尼亚、700106
- 主动,不招人
- Local Institution - 0081
-
Iași、罗马尼亚、700483
- 完全的
- Local Institution - 0080
-
Ploieşti、罗马尼亚、100337
- 主动,不招人
- Local Institution - 0084
-
-
Bistrița-Năsăud County
-
Bistriţa、Bistrița-Năsăud County、罗马尼亚、420020
- 尚未招聘
- Local Institution - 0212
-
接触:
- Site 0212
-
-
Bucharest
-
Bucharest、Bucharest、罗马尼亚、012292
- 完全的
- Local Institution - 0213
-
-
Cluj
-
Florești、Cluj、罗马尼亚、407280
- 主动,不招人
- Local Institution - 0079
-
-
Dolj
-
Craiova、Dolj、罗马尼亚、200746
- 完全的
- Local Institution - 0078
-
-
Timiș County
-
Timișoara、Timiș County、罗马尼亚、300239
- 主动,不招人
- Local Institution - 0085
-
-
-
-
Arkansas
-
Hot Springs、Arkansas、美国、71913
- 尚未招聘
- Local Institution - 0303
-
接触:
- Site 0303
-
-
California
-
Cerritos、California、美国、90703
- 撤销
- Local Institution - 0307
-
Cerritos、California、美国、90703
- 撤销
- Local Institution - 0308
-
Cerritos、California、美国、90703
- 撤销
- Local Institution - 0309
-
Cerritos、California、美国、90703
- 主动,不招人
- Local Institution - 0328
-
Long Beach、California、美国、90805
- 撤销
- Local Institution - 0311
-
Los Angeles、California、美国、90033
- 完全的
- Local Institution - 0290
-
Los Angeles、California、美国、90067
- 完全的
- Local Institution - 0283
-
Newport Beach、California、美国、92663
- 完全的
- Local Institution - 0353
-
Stanford、California、美国、94305
- 撤销
- Local Institution - 0358
-
-
Colorado
-
Aurora、Colorado、美国、80045
- 尚未招聘
- Local Institution - 0289
-
接触:
- Site 0289
-
Denver、Colorado、美国、80220
- 主动,不招人
- Local Institution - 0367
-
-
Delaware
-
Newark、Delaware、美国、19713
- 完全的
- Local Institution - 0304
-
-
Florida
-
Pembroke Pines、Florida、美国、33028
- 撤销
- Local Institution - 0296
-
-
Georgia
-
Atlanta、Georgia、美国、30322
- 完全的
- Local Institution - 0294
-
Atlanta、Georgia、美国、30342
- 完全的
- Local Institution - 0357
-
-
Illinois
-
Chicago、Illinois、美国、60637
- 尚未招聘
- Local Institution - 0280
-
接触:
- Site 0280
-
Chicago、Illinois、美国、60612
- 撤销
- Local Institution - 0278
-
Decatur、Illinois、美国、62526
- 完全的
- Local Institution - 0275
-
O'Fallon、Illinois、美国、62269
- 撤销
- Local Institution - 0324
-
-
Louisiana
-
Covington、Louisiana、美国、70433
- 完全的
- Local Institution - 0286
-
-
Maryland
-
Baltimore、Maryland、美国、21201
- 撤销
- Local Institution - 1035
-
-
Massachusetts
-
Boston、Massachusetts、美国、02114
- 完全的
- Local Institution - 0288
-
Boston、Massachusetts、美国、02215
- 主动,不招人
- Local Institution - 0287
-
-
Michigan
-
Detroit、Michigan、美国、48202
- 完全的
- Local Institution - 0359
-
-
Minnesota
-
Maple Grove、Minnesota、美国、55369
- 完全的
- Local Institution - 0313
-
Minneapolis、Minnesota、美国、55455
- 撤销
- Local Institution - 0372
-
-
Missouri
-
Kansas City、Missouri、美国、64111
- 完全的
- Local Institution - 0284
-
-
New York
-
New York、New York、美国、10016
- 撤销
- Local Institution - 0312
-
New York、New York、美国、10065
- 完全的
- Local Institution - 0279
-
Syracuse、New York、美国、13210
- 撤销
- Local Institution - 1037
-
Westbury、New York、美国、11590
- 完全的
- Local Institution - 0295
-
White Plains、New York、美国、10601
- 完全的
- Local Institution - 0285
-
-
North Carolina
-
Durham、North Carolina、美国、27710
- 完全的
- Local Institution - 0276
-
-
Oregon
-
Eugene、Oregon、美国、97401
- 完全的
- Local Institution - 0316
-
-
Pennsylvania
-
Allentown、Pennsylvania、美国、18103
- 主动,不招人
- Local Institution - 0356
-
Philadelphia、Pennsylvania、美国、19104
- 完全的
- Local Institution - 0310
-
Pittsburgh、Pennsylvania、美国、15213-3403
- 撤销
- Local Institution - 0360
-
-
South Carolina
-
Greenville、South Carolina、美国、29607
- 完全的
- Local Institution - 0281
-
-
Texas
-
Austin、Texas、美国、78705
- 完全的
- Local Institution - 0315
-
El Paso、Texas、美国、79902
- 完全的
- Local Institution - 0368
-
Flower Mound、Texas、美国、75028
- 主动,不招人
- Local Institution - 0305
-
Houston、Texas、美国、77024-2843
- 完全的
- Local Institution - 0314
-
-
Virginia
-
Midlothian、Virginia、美国、23114
- 主动,不招人
- Local Institution - 0277
-
Roanoke、Virginia、美国、24014
- 尚未招聘
- Local Institution - 0301
-
接触:
- Site 0301
-
Winchester、Virginia、美国、22601
- 主动,不招人
- Local Institution - 0302
-
-
-
-
-
Belfast、英国、BT9 7AB
- 撤销
- Local Institution - 0171
-
Manchester、英国、M20 4BX
- 主动,不招人
- Local Institution - 0001
-
Nottingham、英国、NG5 1PB
- 尚未招聘
- Local Institution - 0006
-
接触:
- Site 0006
-
-
England
-
Truro、England、英国、TR1 3LJ
- 完全的
- Local Institution - 0208
-
-
London, City of
-
London、London, City of、英国、SE1 9RT
- 撤销
- Local Institution - 0204
-
London、London, City of、英国、EC1A 7BE
- 主动,不招人
- Local Institution - 0004
-
London、London, City of、英国、SE1 9RT
- 完全的
- Local Institution - 0209
-
-
-
-
-
Coimbra、葡萄牙、3000-075
- 招聘中
- Instituto Portugês de Oncologia de Coimbra Francisco Gentil
-
接触:
- Gabriela Sousa, Site 0124
- 电话号码:+351239400200
-
Lisbon、葡萄牙、1500-650
- 招聘中
- Hospital da Luz Lisboa
-
接触:
- Catarina Pulido, Site 0141
- 电话号码:+351917187738
-
Porto、葡萄牙、4200-072
- 招聘中
- Instituto Português de Oncologia do Porto Francisco Gentil, EPE
-
接触:
- Cristina Oliveira, Site 0111
-
Porto、葡萄牙、4200-319
- 招聘中
- Centro Hospitalar de Sao Joao - Hospital de Sao Joao
-
接触:
- Isabel Augusto, Site 0253
- 电话号码:+351963903409
-
-
Lisbon District
-
Lisbon、Lisbon District、葡萄牙、1649-035
- 招聘中
- Centro Hospitalar Universitário Lisboa Norte, E.P.E. - Hospital de Santa Maria
-
接触:
- Luis Costa, Site 0109
- 电话号码:351217805257
-
Lisbon、Lisbon District、葡萄牙、1400-038
- 尚未招聘
- Local Institution - 0106
-
接触:
- Site 0106
-
Lisbon、Lisbon District、葡萄牙、1099-023
- 招聘中
- Instituto Português de Oncologia de Lisboa Francisco Gentil
-
接触:
- Patricia Pereira, Site 0198
-
-
-
-
-
Madrid、西班牙、28007
- 完全的
- Local Institution - 0107
-
Seville、西班牙、41009
- 招聘中
- Hospital Universitario Virgen Macarena
-
接触:
- Luis de la Cruz Merino, Site 0103
- 电话号码:+34955926578
-
-
A Coruña [La Coruña]
-
A Coruña、A Coruña [La Coruña]、西班牙、15006
- 招聘中
- CHUAC-Hospital Teresa Herrera
-
接触:
- Silvia Antolin Novoa, Site 0105
- 电话号码:+34981178000
-
-
Alicante
-
Elche、Alicante、西班牙、03203
- 招聘中
- Hospital General Universitario de Elche
-
接触:
- Álvaro Rodríguez-Lescure, Site 0100
- 电话号码:111-111-1111
-
-
Barcelona [Barcelona]
-
Barcelona、Barcelona [Barcelona]、西班牙、08035
- 招聘中
- Hospital Universitari Vall d'Hebron
-
接触:
- Ana Mafalda Antunes de Melo e Oliveira, Site 0102
- 电话号码:34934894158
-
Hospitalet、Barcelona [Barcelona]、西班牙、08907
- 完全的
- Local Institution - 0172
-
-
Catalunya [Cataluña]
-
Barcelona、Catalunya [Cataluña]、西班牙、08036
- 招聘中
- Hospital Clínic de Barcelona
-
接触:
- Marta González Rodríguez, Site 0140
- 电话号码:+34606895621
-
-
Gipuzkoa
-
Donostia / San Sebastian、Gipuzkoa、西班牙、20014
- 招聘中
- Hospital Universitario Donostia
-
接触:
- Isabel Alvarez Lopez, Site 0139
- 电话号码:34943006002
-
-
Madrid, Comunidad de
-
Madrid、Madrid, Comunidad de、西班牙、28009
- 招聘中
- Hospital General Universitario Gregorio Marañon
-
接触:
- Sara Lopez Tarruella, Site 0104
- 电话号码:34914269392
-
Madrid、Madrid, Comunidad de、西班牙、28041
- 完全的
- Local Institution - 0108
-
-
Málaga
-
Málaga、Málaga、西班牙、29010
- 招聘中
- Hospital Universitario Virgen de la Victoria
-
接触:
- Maria Emilia Dominguez Recio, Site 0101
- 电话号码:34951291425
-
-
Valenciana, Comunitat
-
Valencia、Valenciana, Comunitat、西班牙、46010
- 招聘中
- Hospital Clinico de Valencia
-
接触:
- Begona Bermejo de las Heras, Site 0210
- 电话号码:34961973583
-
-
-
-
-
Abu Dhabi、阿拉伯联合酋长国
- 撤销
- Local Institution - 0319
-
-
Abu Dhabi Emirate
-
Abu Dhabi、Abu Dhabi Emirate、阿拉伯联合酋长国、11001
- 撤销
- Local Institution - 0323
-
Abu Dhabi、Abu Dhabi Emirate、阿拉伯联合酋长国、92510
- 撤销
- Local Institution - 0318
-
Al Ain City、Abu Dhabi Emirate、阿拉伯联合酋长国、15258
- 撤销
- Local Institution - 0322
-
-
-
-
-
Buenos Aires、阿根廷、1430
- 尚未招聘
- Local Institution - 0346
-
接触:
- Site 0346
-
Buenos Aires、阿根廷、1122
- 完全的
- Local Institution - 0345
-
Buenos Aires、阿根廷、1426
- 主动,不招人
- Local Institution - 0012
-
Buenos Aires、阿根廷、1426
- 主动,不招人
- Local Institution - 0317
-
Mendoza、阿根廷、5500
- 完全的
- Local Institution - 0348
-
-
Buenos Aires
-
Ciudad Autónoma de Buenos Aires、Buenos Aires、阿根廷、1280
- 尚未招聘
- Local Institution - 0011
-
接触:
- Site 0011
-
-
Buenos Aires F.D.
-
ABB、Buenos Aires F.D.、阿根廷、1181
- 完全的
- Local Institution - 0214
-
-
Córdoba Province
-
Córdoba、Córdoba Province、阿根廷、X5004BAL
- 主动,不招人
- Local Institution - 0143
-
Río Cuarto、Córdoba Province、阿根廷、X5800ALB
- 主动,不招人
- Local Institution - 0137
-
-
Santa Fe Province
-
Rosario、Santa Fe Province、阿根廷、2000
- 主动,不招人
- Local Institution - 0142
-
-
-
-
Kyǒnggi-do
-
Goyang-si、Kyǒnggi-do、韩国、10408
- 尚未招聘
- Local Institution - 0066
-
接触:
- Site 0066
-
Seongnam、Kyǒnggi-do、韩国、13620
- 尚未招聘
- Local Institution - 0067
-
接触:
- Site 0067
-
-
Seoul-teukbyeolsi [Seoul]
-
Seoul、Seoul-teukbyeolsi [Seoul]、韩国、02841
- 尚未招聘
- Local Institution - 0068
-
接触:
- Site 0068
-
Seoul、Seoul-teukbyeolsi [Seoul]、韩国、03080
- 尚未招聘
- Local Institution - 0063
-
接触:
- Site 0063
-
Seoul、Seoul-teukbyeolsi [Seoul]、韩国、03722
- 尚未招聘
- Local Institution - 0071
-
接触:
- Site 0071
-
Seoul、Seoul-teukbyeolsi [Seoul]、韩国、05505
- 尚未招聘
- Local Institution - 0064
-
接触:
- Site 0064
-
Seoul、Seoul-teukbyeolsi [Seoul]、韩国、06351
- 尚未招聘
- Local Institution - 0065
-
接触:
- Site 0065
-
-
Taegu-Kwangyǒkshi
-
Daegu、Taegu-Kwangyǒkshi、韩国、41404
- 尚未招聘
- Local Institution - 0069
-
接触:
- Site 0069
-
-
参与标准
资格标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria
-
Histologically or cytologically confirmed and documented locally-advanced, recurrent inoperable, or metastatic triple-negative breast cancer (TNBC) (ER < 1%, PgR < 1%, HER2 IHC 0, 1+, or 2+ with ISH negative for HER2 gene amplification) or ER-low, HER2-negative BC (ER and / or PgR 1% to 10%, HER2 IHC 0, 1+, or 2+ with ISH negative for HER2 gene amplification) per American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) criteria, based on the most recently analyzed biopsy or other pathology specimen.
-
Patients with recurrent disease must have experienced disease relapse at least 6 months after finishing their last therapy with curative intent.
-
Participants with TNBC must be considered ineligible for 1L chemotherapy combination treatment with an anti-PD-1 (eg, pembrolizumab) or an anti-PD-L1 (eg, atezolizumab) due to any one of the following criteria:
i) Investigator-determined ineligibility based on PD-L1 negative disease determined and documented prior to trial screening as part of standard of care (SoC); ii) Has experienced disease relapse between 6 to 12 months after the completion of (neo)adjuvant therapy with an anti-PD(L)1; iii) Has a severe auto-immune disease or other contraindication, in the opinion of the investigator, for the use of an anti-PD(L)1 drug: iv) Any auto-immune disease that requires current immunosuppression (eg, methotrexate, cyclophosphamide, prednisone > 10 mg/day).
v) Prior auto-immune AE to peri-adjuvant ICI that required immunosuppression. vi) Current Graves' disease with ophthalmopathy or in need of radioiodine or in use of antithyroid medication.
vii) Current or prior auto-immune diseases per below: A. Moderate to severe rheumatoid arthritis. B. Auto-immune hepatitis or cholangitis. C. Myasthenia gravis. D. Moderate-to-severe or poorly controlled inflammatory bowel disease. E. Multiple sclerosis. F. Lupus with kidney involvement or moderate to severe lupus. G. Auto-immune myocarditis. Note: if participant meets Inclusion Criteria 5b or 5c, unknown PDL1 results per local SOC are acceptable in these specific cases.
- Patients with ER-low, HER2-negative BC must be ineligible, in the opinion of the Investigator, for endocrine therapy-based treatments.
- No previous systemic therapy in the locally advanced, recurrent inoperable or metastatic setting (ie incurable setting).
- Measurable disease by CT or MRI as per RECIST v1.1.
Exclusion Criteria
-
Participants with a known germline breast cancer gene (BRCA) 1 or 2 mutation whose best 1L treatment option, in the opinion of the investigator, is a poli-ADP-ribose-polymerase inhibitors (PARPi).
-
Untreated symptomatic central nervous system (CNS) metastases. Participants are eligible if CNS metastases have been treated, and participants' neurological signs and symptoms have returned to baseline. In addition, participants must have been either off corticosteroids, or on a stable or decreasing dose of ≤ 10 mg daily prednisone (or equivalent) for at least 2 weeks prior to randomization. Imaging performed within 28 days of randomization must document radiographic stability of CNS lesions and be performed after completion of any CNS directed therapy.
-
Leptomeningeal metastases.
-
Participants with history of severe heart disease including, but not limited to, any of the following:
i) History of clinically significant heart disease (eg, cardiomyopathy, congestive heart failure with New York Heart Association functional classification II to IV, pericarditis, or significant pericardial effusion).
ii) Myocardial infarction, uncontrolled angina, or stroke/transient ischemic attack within the past 6 months.
iii) QTc (by Fridericia's formula) prolongation ≥ 450 msec for males and ≥ 470 msec for females, except for right bundle branch block.
iv) Known LVEF < 50%.
- Prior therapy with iza-bren or any other ADC targeting EGFR and/or HER3 or containing a topoisomerase 1 inhibitor payload.
- Other protocol-defined Inclusion/Exclusion criteria apply.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
手臂数量
武器和干预
参与者组/臂参与者组/臂 |
干预/治疗干预/治疗 |
|---|---|
|
有源比较器:B臂
|
Specified dose on specified days Specified dose on specified days Specified dose on specified days Specified dose on specified days Specified dose on specified days |
|
实验性的:臂A1
|
Specified dose on specified days
其他名称:
|
|
实验性的:臂A2
|
Specified dose on specified days
其他名称:
|
研究衡量的是什么?
主要结果指标
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Recommended Phase 3 Dose (RP3D) of BMS-986507
大体时间:Approximately 13 months from first participant randomization in Phase 2
|
Approximately 13 months from first participant randomization in Phase 2
|
|
|
Progression-Free Survival (PFS)
大体时间:Approximately 22 months from first participant randomization in Phase 3
|
Assessed using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) by blinded independent central review (BICR) |
Approximately 22 months from first participant randomization in Phase 3
|
次要结果测量
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Overall Survival (OS)
大体时间:Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with treatment-related Adverse Events (AEs)
大体时间:Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with laboratory abnormalities
大体时间:Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with serious AEs (SAEs)
大体时间:Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with AEs leading to treatment discontinuation, interruption, dose reduction or dose delay
大体时间:Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of deaths
大体时间:Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Objective Response (OR) per BICR
大体时间:Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Objective Response (OR) per Investigator
大体时间:Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Relative change in tumor size
大体时间:Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Disease control rate (DCR) per BICR
大体时间:Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Disease control rate (DCR) per Investigator
大体时间:Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Duration of Response (DOR) per BICR
大体时间:Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Duration of response (DOR) per Investigator
大体时间:Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Time to Response (TTR) per BICR
大体时间:Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Time to response (TTR) per Investigator
大体时间:Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Change from baseline in European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30)
大体时间:Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Change from baseline in EORTC Breast Cancer-specific Quality of Life Questionnaire (QLQ-BR23)
大体时间:Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Functional Assessment of Chronic Illness Therapy item GP5 (FACIT GP5) score
大体时间:Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Change from baseline in European Quality of Life 5 Dimensions 5 Levels (EQ-5D-5L)
大体时间:Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
PFS rate
大体时间:Approximately 22 months from first participant randomization in Phase 3
|
Assessed using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) by BICR |
Approximately 22 months from first participant randomization in Phase 3
|
|
PFS rate
大体时间:Approximately 22 months from first participant randomization in Phase 3
|
Assessed using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) by Investigator |
Approximately 22 months from first participant randomization in Phase 3
|
|
PFS
大体时间:Approximately 22 months from first participant randomization in Phase 3
|
Assessed by Investigator |
Approximately 22 months from first participant randomization in Phase 3
|
|
Time to subsequent treatment (TTST) per Investigator
大体时间:Approximately up to 47 months from first participant randomization in Phase 3
|
Defined as time from randomization to the start of subsequent therapy or death |
Approximately up to 47 months from first participant randomization in Phase 3
|
|
Progression-free survival after next line of treatment (PFS2)
大体时间:Approximately up to 47 months from first participant randomization in Phase 3
|
Defined as the time from randomization to the date of investigator-defined documented disease progression after next line of treatment or death due to any cause, whichever comes first |
Approximately up to 47 months from first participant randomization in Phase 3
|
合作者和调查者
调查人员
调查人员
- 研究主任:Bristol-Myers Squibb、Bristol-Myers Squibb
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
学习开始
初级完成 (估计的)
初级完成
研究完成 (估计的)
研究完成
研究注册日期
首次提交
首次提交
首先提交符合 QC 标准的
首先提交符合 QC 标准的
首次发布 (实际的)
首次发布
研究记录更新
最后更新发布 (实际的)
最后更新发布
上次提交的符合 QC 标准的更新
上次提交的符合 QC 标准的更新
最后验证
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
其他研究编号
- CA244-0008
- 2024-519871-24 (其他标识符:EU CTR)
- U1111-1316-1533 (其他标识符:WHO)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html
IPD 共享时间框架
See Plan Description
IPD 共享访问标准
See Plan Description
IPD 共享支持信息类型
- 研究方案
- 树液
- 企业社会责任
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.